DermTech, Inc.

DermTech, Inc. (Nasdaq: DMTK) is a precision dermatology company specializing in genomics-based, non-invasive skin diagnostics, primarily targeting early melanoma detection through its proprietary Smart Sticker adhesive patch technology. The company entered the public markets in 2019 via a merger with Constellation Alpha Capital Corp., a healthcare-focused special purpose acquisition company sponsored by Constellation Alpha Capital LLC. DermTech operates in the molecular diagnostics and precision medicine sector and filed a quarterly report on Form 10-Q with the SEC on May 15, 2024, covering its first-quarter operating results. To access full filing data, deal history, and analytics on DermTech and hundreds of other SPAC transactions, sign up at SpacDesk.